로딩 중…
지수 로딩 중…
Palvella Therapeutics, Inc.
PVLA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$113.10+0.42%
2026-06-18
Price Chart
Palvella Therapeutics, Inc.+451.44%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.62B |
| Revenue | $0.00 |
| Net Income | $-49M |
| Total Assets | $264M |
| Net Assets | $232M |
| Value | |
| P/B | 6.98x |
| FCF Yield | -1.79% |
| Profitability | |
| ROE | -21.22% |
| ROA | -18.69% |
| Financial Health | |
| Debt Ratio | 13.54% |
| Total Debt | $584000.00 |
| FCF | $-29M |
| Cash | $206M |
| Current Ratio | 28.88x |
| Performance | |
| 1Y Return | 451.44% |
| 1M Return | 3.57% |
| From 52W High | -25.19% |
| 1Y MDD | -31.11% |
| Trading | |
| Volume | 296,683 shares |
| Trading Value | $34M |
| Per Share | |
| EPS | $-3.71 |
| BPS | $2.49 |